{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:12:04Z","timestamp":1793045524648,"version":"4.5.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T00:00:00Z","timestamp":1650499200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T00:00:00Z","timestamp":1650499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Gallbladder cancer is associated with late diagnosis and poor prognosis. Current study aims to develop a prognostic nomogram for predicting survival of gallbladder cancer patients after surgery.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Two large cohorts were included in this analysis. One consisted of 1753 gallbladder cancer patients from the Surveillance, Epidemiology, and End Results (SEER) database, and the other consisted of 239 patients from Shanghai Renji hospital. Significant prognostic factors were identified and integrated to develop the nomogram. Then the model was subjected to bootstrap internal validation and external validation.\n<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Univariate and multivariate analysis indicated that age, tumor histology, T-stage, N-stage and M-stage were significant prognostic factors, which were all included to build the nomogram. The model showed good discrimination, with a concordance index (C-index) of 0.724 (95% CI, 0.708\u20130.740), and good calibration. Application of the nomogram in the validation cohort still presented good discrimination (C-index, 0.715 [95% CI 0.672\u20130.758]) and good calibration. In the primary cohort, the C-index of the nomogram was 0.724, which was significantly higher than the Nevin staging system (C-index\u2009=\u20090.671; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001) and the 8th TNM staging system (C-index\u2009=\u20090.682; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). In the validation cohort, the C-index of the nomogram was 0.715, which was also higher than the Nevin staging system (C-index\u2009=\u20090.692; <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.05) and the 8th TNM staging system (C-index\u2009=\u20090.688; <jats:italic>P<\/jats:italic>\u2009=\u20090.06).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The proposed nomogram resulted in more-accurate prognostic prediction for patients with gallbladder cancer after surgery.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12876-022-02281-2","type":"journal-article","created":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T17:04:43Z","timestamp":1650560683000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Development and validation of a prognostic nomogram for gallbladder cancer patients after surgery"],"prefix":"10.1186","volume":"22","author":[{"given":"Xinsen","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2322-4050","authenticated-orcid":false,"given":"Linhua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,21]]},"reference":[{"issue":"2","key":"2281_CR1","doi-asserted-by":"publisher","first-page":"93","DOI":"10.5114\/ceh.2019.85166","volume":"5","author":"P Rawla","year":"2019","unstructured":"Rawla P, Sunkara T, Thandra KC, Barsouk A. Epidemiology of gallbladder cancer. Clin Exp Hepatol. 2019;5(2):93\u2013102.","journal-title":"Clin Exp Hepatol"},{"key":"2281_CR2","doi-asserted-by":"crossref","unstructured":"Sung YN, Song M, Lee JH, Song KB, Hwang DW, Ahn CS, Hwang S, Hong SM. Validation of the 8th Edition of the American Joint Committee on cancer staging system for gallbladder cancer and implications for the follow-up of patients without node dissection. Cancer Res Treat. 2020;52(2):455\u201368.","DOI":"10.4143\/crt.2019.271"},{"issue":"4","key":"2281_CR3","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.21037\/jgo-21-357","volume":"12","author":"Z Yang","year":"2021","unstructured":"Yang Z, Ren T, Liu S, Cai C, Gong W, Shu Y. Preoperative serum fibrinogen as a valuable predictor in the nomogram predicting overall survival of postoperative patients with gallbladder cancer. J Gastrointest Oncol. 2021;12(4):1661\u201372.","journal-title":"J Gastrointest Oncol"},{"issue":"12","key":"2281_CR4","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/ncpuro0968","volume":"4","author":"MW Kattan","year":"2007","unstructured":"Kattan MW, Scardino PT. Evidence for the usefulness of nomograms. Nat Clin Pract Urol. 2007;4(12):638\u20139.","journal-title":"Nat Clin Pract Urol"},{"issue":"1","key":"2281_CR5","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1093\/jnci\/djv291","volume":"108","author":"LQ Tang","year":"2016","unstructured":"Tang LQ, Li CF, Li J, Chen WH, Chen QY, Yuan LX, Lai XP, He Y, Xu YX, Hu DP, et al. Establishment and validation of prognostic nomograms for endemic nasopharyngeal carcinoma. J Natl Cancer Inst. 2016;108(1):66.","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"2281_CR6","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1200\/JCO.2012.41.5984","volume":"31","author":"Y Wang","year":"2013","unstructured":"Wang Y, Li J, Xia Y, Gong R, Wang K, Yan Z, Wan X, Liu G, Wu D, Shi L, et al. Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy. J Clin Oncol. 2013;31(9):1188\u201395.","journal-title":"J Clin Oncol"},{"issue":"8","key":"2281_CR7","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1200\/JCO.2014.56.6661","volume":"33","author":"W Liang","year":"2015","unstructured":"Liang W, Zhang L, Jiang G, Wang Q, Liu L, Liu D, Wang Z, Zhu Z, Deng Q, Xiong X, et al. Development and validation of a nomogram for predicting survival in patients with resected non-small-cell lung cancer. J Clin Oncol. 2015;33(8):861\u20139.","journal-title":"J Clin Oncol"},{"issue":"18","key":"2281_CR8","doi-asserted-by":"publisher","first-page":"2157","DOI":"10.1200\/JCO.2015.65.9128","volume":"34","author":"YQ Huang","year":"2016","unstructured":"Huang YQ, Liang CH, He L, Tian J, Liang CS, Chen X, Ma ZL, Liu ZY. Development and validation of a radiomics nomogram for preoperative prediction of lymph node metastasis in colorectal cancer. J Clin Oncol. 2016;34(18):2157\u201364.","journal-title":"J Clin Oncol"},{"issue":"13","key":"2281_CR9","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1200\/JCO.2007.14.7934","volume":"26","author":"SJ Wang","year":"2008","unstructured":"Wang SJ, Fuller CD, Kim JS, Sittig DF, Thomas CR Jr, Ravdin PM. Prediction model for estimating the survival benefit of adjuvant radiotherapy for gallbladder cancer. J Clin Oncol. 2008;26(13):2112\u20137.","journal-title":"J Clin Oncol"},{"issue":"35","key":"2281_CR10","doi-asserted-by":"publisher","first-page":"4627","DOI":"10.1200\/JCO.2010.33.8020","volume":"29","author":"SJ Wang","year":"2011","unstructured":"Wang SJ, Lemieux A, Kalpathy-Cramer J, Ord CB, Walker GV, Fuller CD, Kim JS, Thomas CR Jr. Nomogram for predicting the benefit of adjuvant chemoradiotherapy for resected gallbladder cancer. J Clin Oncol. 2011;29(35):4627\u201332.","journal-title":"J Clin Oncol"},{"issue":"23","key":"2281_CR11","doi-asserted-by":"publisher","first-page":"738","DOI":"10.21037\/atm.2019.11.112","volume":"7","author":"Z Xiao","year":"2019","unstructured":"Xiao Z, Shi Z, Hu L, Gao Y, Zhao J, Liu Y, Xu Q, Huang D. A new nomogram from the SEER database for predicting the prognosis of gallbladder cancer patients after surgery. Ann Transl Med. 2019;7(23):738.","journal-title":"Ann Transl Med"},{"issue":"14","key":"2281_CR12","doi-asserted-by":"publisher","first-page":"3246","DOI":"10.7150\/jca.30046","volume":"10","author":"M Chen","year":"2019","unstructured":"Chen M, Cao J, Zhang B, Pan L, Cai X. A nomogram for prediction of overall survival in patients with node-negative gallbladder cancer. J Cancer. 2019;10(14):3246\u201352.","journal-title":"J Cancer"},{"issue":"1","key":"2281_CR13","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41598-017-00491-3","volume":"7","author":"ZQ Cai","year":"2017","unstructured":"Cai ZQ, Guo P, Si SB, Geng ZM, Chen C, Cong LL. Analysis of prognostic factors for survival after surgery for gallbladder cancer based on a Bayesian network. Sci Rep. 2017;7(1):293.","journal-title":"Sci Rep"},{"issue":"6","key":"2281_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0198809","volume":"13","author":"S Samuel","year":"2018","unstructured":"Samuel S, Mukherjee S, Ammannagari N, Pokuri VK, Kuvshinoff B, Groman A, LeVea CM, Iyer R. Clinicopathological characteristics and outcomes of rare histologic subtypes of gallbladder cancer over two decades: a population-based study. PLoS ONE. 2018;13(6): e0198809.","journal-title":"PLoS ONE"},{"issue":"13","key":"2281_CR15","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.4103\/0366-6999.159356","volume":"128","author":"XS Xu","year":"2015","unstructured":"Xu XS, Chen W, Miao RC, Zhou YY, Wang ZX, Zhang LQ, Qu K, Pang Q, Wang RT, Liu C. Survival analysis of hepatocellular carcinoma: a comparison between young patients and aged patients. Chin Med J. 2015;128(13):1793\u2013800.","journal-title":"Chin Med J"},{"issue":"1","key":"2281_CR16","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1186\/s13063-019-3605-z","volume":"20","author":"M He","year":"2019","unstructured":"He M, Xu X, Feng H, Chen W, Liu H, Zhang Y, Wang J, Geng Z, Qiu Y, Duan W, et al. Regional lymphadenectomy vs. extended lymphadenectomy for hilar cholangiocarcinoma (Relay-HC trial): study protocol for a prospective, multicenter, randomized controlled trial. Trials. 2019;20(1):528.","journal-title":"Trials"},{"issue":"8","key":"2281_CR17","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1038\/ng.3030","volume":"46","author":"M Li","year":"2014","unstructured":"Li M, Zhang Z, Li X, Ye J, Wu X, Tan Z, Liu C, Shen B, Wang XA, Wu W, et al. Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway. Nat Genet. 2014;46(8):872\u20136.","journal-title":"Nat Genet"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-022-02281-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-022-02281-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-022-02281-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T17:07:15Z","timestamp":1650560835000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-022-02281-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,21]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2281"],"URL":"https:\/\/doi.org\/10.1186\/s12876-022-02281-2","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,21]]},"assertion":[{"value":"25 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethical Committee of Renji hospital, Shanghai Jiao Tong University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"200"}}